(2R,3S,4S)-1-[(2S)-2-acetamido-3,3-dimethylbutanoyl]-3-fluoro-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide is a next-generation ligand specifically engineered for VHL (von Hippel-Lindau) E3 ligase recruitment in PROTAC technology. As an E3 Ligase Ligand, this molecule enables selective protein degradation by facilitating ubiquitination and subsequent proteasomal removal of target proteins. With its optimal binding affinity and chemical handle for conjugation, it is ideal for constructing bifunctional degraders in drug discovery and chemical biology. Suitable for research in targeted protein degradation, this ligand empowers the design of potent and selective PROTACs against a broad range of disease-associated proteins.
Structure of 2211116-18-4
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
(2R,3S,4S)-1-[(2S)-2-acetamido-3,3-dimethylbutanoyl]-3-fluoro-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide is a highly specialized ligand designed for recruiting the Von Hippel-Lindau (VHL) E3 ubiquitin ligase. As part of the rapidly advancing field of targeted protein degradation, this compound serves as a critical E3 ligase ligand for constructing PROTACs (Proteolysis Targeting Chimeras) and other heterobifunctional degraders. VHL-based ligands provide an orthogonal approach to more commonly used CRBN ligands, enabling the selective degradation of disease-relevant proteins in drug discovery and research settings.
Mechanism
This compound functions as a high-affinity ligand for the VHL E3 ligase complex. By binding to the VHL protein, it acts as the E3 ligase-recruiting moiety in bifunctional PROTAC molecules. When chemically linked to a ligand that targets a protein of interest, the resulting PROTAC brings the target protein into close proximity with the VHL ligase, promoting target ubiquitination and subsequent recognition and degradation by the cellular proteasome system. Key features such as the fluorine and 4-hydroxy substitutions contribute to increased binding affinity and metabolic stability, optimizing its performance in degrader applications.
Applications
(2R,3S,4S)-1-[(2S)-2-acetamido-3,3-dimethylbutanoyl]-3-fluoro-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide is ideal for a range of research and drug discovery projects focusing on targeted protein degradation. Main applications include:
• Synthesis of VHL-based PROTACs to induce selective degradation of oncoproteins, transcription factors, and other disease-associated targets.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.